Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01620008 · ClinicalTrials.gov registry record · NA

Delayed Cord Clamping and Infant Brain Study

A NA study of Iron-deficiency, sponsored by University of Rhode Island.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT01620008 is a NA study of Iron-deficiency that has completed, run by University of Rhode Island. The registered enrollment target is 106 participants, below the 192-participant average among 16 other Iron-deficiency trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01620008, a NA study of Iron-deficiency, has completed, sponsored by University of Rhode Island.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if delaying cord clamping at the birth of term infants effects the early brain development (myelin deposition)as determined by quantitative MRI at 4 and 10 months and developmental testing at 4, 10 and 24 months. This study will help to establish a scientific basis for the timing of cord clamping with reference to brain development.

Conditions Studied

Interventions

  • PROCEDURE Delayed Cord Clamping

Study Locations (1)

Rhode Island

  • Women & Infants Hospital of Rhode Island - Providence

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2012-10-01
Est. Completion 2018-12-31
Phase NA

Sponsor

University of Rhode Island

29 total trials

What the Registry Record Tells You About NCT01620008

The ClinicalTrials.gov registry entry for NCT01620008 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 16 other Iron-deficiency trials with a reported enrollment target (45% lower). The listed sponsor is University of Rhode Island, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Iron-deficiency appearing as the primary indexed condition, and to 1 intervention - of which Delayed Cord Clamping is the first listed.

NCT01620008 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01620008 about?

NCT01620008 is a clinical study titled "Delayed Cord Clamping and Infant Brain Study". The purpose of this study is to determine if delaying cord clamping at the birth of term infants effects the early brain development (myelin deposition)as determined by quantitative MRI at 4 and 10 months and developmental testing at 4, 10 and 24 months. This study will help to establish a scientifi...

What is the current status of trial NCT01620008?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2012-10-01. Estimated completion is 2018-12-31.

What conditions does trial NCT01620008 study?

This clinical trial studies the following conditions: Iron-deficiency.

What interventions are being tested in trial NCT01620008?

The interventions under investigation include: Delayed Cord Clamping (PROCEDURE).

Who is sponsoring clinical trial NCT01620008?

This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01620008 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Iron-deficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.